| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT01353482 2009-013638-26 Details | 2012-03-22 Interventional | 1/2 | 0 | Pemetrexed Vorinostat Mesothelioma Mesothelioma, M… Malignant Pleur… | UCL CTC were informed by Merck Sharp & Dohme on 22.08.11 that support for the trial had been
withdrawn in light of results from another trial with trial drug. - | |||
| NCT01044225 2009-012324-83 Details | 2012-03-22 Interventional | 2 | 12 | Cetuximab Glioblastoma | Results of the phase III RTOG0525 trial made the manufacturer of cilengitide decide to end
their support to the trial - | |||
| NCT00586365 Details | 2012-03-21 Interventional | 4 | 0 | Naproxen Ossification, H… Heterotopic Oss… | Too difficult to satisfy all the inclusion criteria. - | |||
| NCT01517308 Details | 2012-03-19 Interventional | 3 | 0 | Interferon alph… Interferon-alph… Interferons Peginterferon a… Ribavirin Hepatitis Hepatitis A Hepatitis C Hepatitis C, Ch… Hepatitis, Chro… Chronic Hepatit… | Time elapsed to require permissions and a recent paper showed a high efficacy of a 48-week
regimen in this setting. It seems non-ethical to start this trial - | |||
| NCT00799760 2008-004026-16 Details | 2012-03-19 Interventional | 3 | [1 Refs] | 541 | Oseltamivir Zanamivir Influenza, Huma… Gastric Influen… | Just Terminated for the end of the pandemia - | ||
| NCT00281125 Details | 2012-03-19 Interventional | 1/2 | - | Pemetrexed Vatalanib Carcinoma, Non-… Lung Neoplasms Mesothelioma Mesothelioma, M… Non-Small Cell … | Suspended due to data issues revealed at DSMB meeting. Planned amendment but was never
submitted. Study was then closed. - | |||
| NCT00532038 Details | 2012-03-16 Interventional | 3 | 179 | Ketoprofen Osteoarthritis Osteoarthritis,… | Corporate decision - | |||
| NCT00528827 Details | 2012-03-16 Interventional | 2 | 0 | Nicardipine Hypertension | Due to the sale of Cardene IV, the sponsor has stopped enrollment and withdrawn the study. No
safety issues were identified. - | |||
| NCT01162889 Details | 2012-03-15 Interventional | 1 | 70 | Antibodies, Mon… Healthy | See termination reason in detailed description. - | |||
| NCT01436032 Details | 2012-03-14 Interventional | 3 | 50 | Ketorolac Ketorolac Trome… Laparoscopic Su… | - - | |||
| NCT01066468 2010-018418-53 Details | 2012-03-13 Interventional | 1 | 3 | Imatinib Mesyla… Hematologic Dis… Leukemia Leukemia, Lymph… Leukemia, Myelo… Leukemia, Myelo… Philadelphia Ch… Precursor Cell … Chronic Myeloid… Other Glivec/Gl… Philadelphia Ch… | - - | |||
| NCT00518284 Details | 2012-03-13 Interventional | 2 | 6 | Albumin-Bound P… Paclitaxel Peripheral Arte… Peripheral Vasc… Vascular Diseas… Vascular Diseas… | Study was terminated due to changing sponsor priorities, and was not based on safety or
outcomes data. - | |||
| NCT00279435 Details | 2012-03-12 Interventional | 2/3 | 25 | Visilizumab Colitis Colitis, Ulcera… Ulcer Ulcerative Coli… | company decision based on other studies - | |||
| NCT00279422 Details | 2012-03-12 Interventional | 2/3 | 127 | Visilizumab Colitis Colitis, Ulcera… Ulcer Ulcerative Coli… | DMC recommendation, no efficacy - | |||
| NCT01545427 Details | 2012-03-07 Interventional | 2 | 10 | Imatinib Mesyla… Scleroderma, Di… Scleroderma, Lo… Scleroderma, Sy… Scleroderma | Frequent adverse events occurred early in treatment with poor tolerability. - | |||
| NCT01409408 Details | 2012-03-06 Interventional | 4 | 0 | Aliskiren Amlodipine Diabetes Mellit… Hypertension | Due to preliminary results of Altitude Trial. - | |||
| NCT00998101 Details | 2012-03-06 Interventional | 2 | 0 | Carboplatin Cetuximab Carcinoma, Non-… Lung Neoplasms Lung Cancer | Study was withdrawn due issuses related to the science - | |||
| NCT00881673 Details | 2012-03-06 Interventional | 2 | 0 | Dexamethasone Ophthalmic Solu… Conjunctivitis Conjunctivitis,… Allergic Conjun… | Management decision - | |||
| NCT00741845 Details | 2012-03-06 Interventional | 3 | 117 | Metronidazole Vaginal Disease… Vaginosis, Bact… Bacterial Vagin… | Terminated for site documentation and monitoring issues - not safety, study drug, or adverse
event issues. - | |||
| NCT00572182 NCT00923208 Details | 2012-03-06 Interventional | 1 | 33 | 3-(4-((4-chloro… Central Nervous… Nervous System … Brain and Centr… | This Phase I study was permanently closed to patient accrual on February 23, 2011, due to the
discontinuation of support from MERCK. - |